During the NAMCP Spring Managed Care Forum 2018, Robert M Rifkin, MD, FACP, medical director of biosimilars at McKesson Specialty Health, The US Oncology Network, explained how biosimilars can add value by increasing access and decreasing...
During the NAMCP Spring Managed Care Forum 2018, Robert M Rifkin, MD, FACP, medical director of biosimilars at McKesson Specialty Health, The US Oncology Network, explained how biosimilars can add value by increasing access and decreasing...
During the NAMCP Spring Managed...